# Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers

> **NCT01508832** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 12 (actual)

## Conditions studied

- Onset and Duration of a Digital Nerve Block

## Interventions

- **DRUG:** Lidocaine Digital Nerve Block
- **DRUG:** Bupivacaine Digital Block

## Key facts

- **NCT ID:** NCT01508832
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508832, "Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01508832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*